Skip to main content

Table 2 Summary of remifentanil and sufentanil doses in patients with BPS 3 and 4

From: Measurement of the nociceptive flexion reflex threshold in critically ill patients – a randomized observational pilot study

Specialty

BPS

NFRT Remifentanil *

[mA]

Remifentanil*

[mg/h]

NFRT Sufentanil*

[mA]

Sufentanil*

[μg/h]

Neurosurgery/ brain hemorrhage

3

19.20

[15.00 – 39.45]

0.20

[0.20 – 0.30]

30.50

[19.57 – 37.75]

10.00

[10.00 – 13.12]

Abdominal surgery

3

42.50

[33.90 – 58.30]

0.30

[0.23 – 0.40]

41.80

[25.75 – 72.00]

10.00

[0.01 – 10.00]

Trauma surgery

3

25.00

[15.30 – 33.75]

0.60

[0.40 – 0.60]

61.43

[34.03 – 87.08]

15,00

[15.00 – 20.00]

Thoracic surgery

3

22.25

[11.95 – 35.27]

0.20

[0.10 – 0.20]

  

Respiratory failure

3

35.5

[18.89 – 42.65]

0.20

[0.20 – 0.20]

89.00

[82.50 – 93.25]

20.00

[18.75 – 20.00]

Urology

3

17.00

[11.50 – 34.20]

0.30

[0.30 – 0.40]

  

Neurosurgery/brain hemorrhage

4

n.e.

n.e.

  

Trauma surgery

4

n.e.

n.e.

  

Respiratory failure

4

n.e.

n.e.

  

Urology

4

n.e.

n.e.

  

Thoracic surgery

4

18.90

[14.30 – 50.10]

0,30

[0.100 – 0.30]

  

Abdominal surgery

4

40.50

[29.52 – 77.50]

0.30

[0.21 – 0.40]

  
  1. * Median, IQR n.e. = not established, too few individual values to calculate the descriptive statistics